| 1 |
21346624 | Interactive effect of angiotensin II type 1 receptor (AGT1R) polymorphisms and plasma irbesartan concentration on antihypertensive therapeutic responses to irbesartan. | 2011 May |
1 |
| 2 |
17407587 | Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients. | 2007 Apr 3 |
2 |
| 3 |
16541193 | CYP2C9 Ile359Leu polymorphism, plasma irbesartan concentration and acute blood pressure reductions in response to irbesartan treatment in Chinese hypertensive patients. | 2006 Jan-Feb |
1 |
| 4 |
15897788 | Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension. | 2005 Jun |
1 |
| 5 |
15071488 | Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus. | 2004 Oct |
1 |
| 6 |
12681201 | [Effect of anti-hypertensive therapy with irbesartan on the absolute cardiovascular risk]. | 2003 Apr |
1 |
| 7 |
12522893 | [Comparison of the antihypertensive activity of fosinopril and irbesartan]. | 2002 Nov |
1 |
| 8 |
8797143 | Dose-ranging study of the angiotensin II receptor antagonist irbesartan (SR 47436/BMS-186295) on blood pressure and neurohormonal effects in salt-deplete men. | 1996 Jul |
1 |